Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
DRUGNAME | PT | EventCount |
---|---|---|
Rituximab | Peripheral sensorimotor neuropathy | 2 |
Rituximab | Peripheral sensory neuropathy | 2 |
rituximab | Plasma cell myeloma | 2 |
Rituximab | Polyomavirus-associated nephropathy | 2 |
Rituximab | Postoperative wound infection | 2 |
rituximab | Primary mediastinal large B-cell lymphoma | 2 |
Rituximab | Product taste abnormal | 2 |
Rituximab | Pseudomonal sepsis | 2 |
Rituximab | Pubis fracture | 2 |
RITUXIMAB | Pulmonary thrombosis | 2 |
Rituximab | Pulseless electrical activity | 2 |
Rituximab | Rash papular | 2 |
RITUXIMAB | Renal cell carcinoma | 2 |
Rituximab | Renal disorder | 2 |
Rituximab | Renal neoplasm | 2 |
Rituximab | Retinal detachment | 2 |
Rituximab | Retinal haemorrhage | 2 |
Rituximab | Rheumatoid nodule | 2 |
RITUXIMAB | Rhinovirus infection | 2 |
Rituximab | Second primary malignancy | 2 |
Total Records: 1,104 Number of Pages: 56